Skip to main content
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

ProKidney Corp. - Class A Ordinary Shares (NQ:PROK)

2.480 -0.500 (-16.78%)
Streaming Delayed Price Updated: 4:00 PM EDT, Sep 12, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 8,276,529
Open 3.000
Bid (Size) 2.500 (4)
Ask (Size) 2.510 (1)
Prev. Close 2.980
Today's Range 2.371 - 3.050
52wk Range 0.4603 - 7.130
Shares Outstanding 61,540,231
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Which stocks are experiencing notable movement on Friday?
Wondering how the US markets performed one hour before the close of the markets on Friday? Discover the movers and shakers of today's session in our comprehensive analysis. 
Via Chartmill
What's going on in today's session
Curious to know what's happening on the US markets one hour before the close of the markets on Thursday? Join us as we explore the top gainers and losers in today's session. 
Via Chartmill

Performance

YTD
+43.4%
+43.4%
1 Month
+4.6%
+4.6%
3 Month
+195.8%
+195.8%
6 Month
+152.1%
+152.1%
1 Year
+4.2%
+4.2%

More News

Read More
12 Health Care Stocks Moving In Thursday's Intraday Session
Via Benzinga
ProKidney to Participate in Two Upcoming Conferences: the Citi Biopharma Back to School Conference and the Morgan Stanley Global Healthcare Conference
From ProKidney
Via GlobeNewswire
Prediction: Chamath Palihapitiya's $250 Million SPAC Could Create the Next Palantir for America's Energy Grid
Via The Motley Fool
Topics Artificial Intelligence Economy
Chamath Palihapitiya Returns To SPACs: Past 18 Deals, Investments Average Loss Of 14%
Via Benzinga
ProKidney Reports 78 Percent Gain in Q2
Via The Motley Fool
Topics Intellectual Property
ProKidney Corp (NASDAQ:PROK) Reports Mixed Q2 2025 Results with Regulatory Progress and Narrower Loss
Via Chartmill
ProKidney Reports Second Quarter 2025 Financial Results and Provides Regulatory and Clinical Updates
From ProKidney
Via GlobeNewswire
Meet the Biotech Stock That Rocketed 775% Higher
Via The Motley Fool
This Biotech Stock Jumped Over 600% in Just Days After Releasing Promising Clinical Trial Data. And Its Market Cap Is Still Only $2 Billion. But Is It a Buy?
Via The Motley Fool
Unusual volume stocks are being observed in Tuesday's session.
Via Chartmill
Simulations Plus, FB Financial And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session
Via Benzinga
ProKidney Announces Alignment with the FDA on the Accelerated Approval Pathway for Rilparencel
From ProKidney
Via GlobeNewswire
These stocks are moving in today's session
Via Chartmill
12 Health Care Stocks Moving In Thursday's Intraday Session
Via Benzinga
In today's session, these stocks are experiencing unusual volume.
Via Chartmill
AZZ Posts Better-Than-Expected Earnings, Joins MP Materials, WK Kellogg And Other Big Stocks Moving Higher On Thursday
Via Benzinga
Get insights into the top gainers and losers of Thursday's pre-market session.
Via Chartmill
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Via Benzinga
Why WK Kellogg Shares Are Trading Higher By Over 50%; Here Are 20 Stocks Moving Premarket
Via Benzinga
Which stocks are most active on Wednesday?
Via Chartmill
Which stocks have an unusual volume on Wednesday?
Via Chartmill
These stocks are moving in today's session
Via Chartmill
ProKidney (PROK) Shares Skyrocket On Promising Kidney Disease Drug Trial Results
Via Benzinga

Frequently Asked Questions

Is ProKidney Corp. - Class A Ordinary Shares publicly traded?
Yes, ProKidney Corp. - Class A Ordinary Shares is publicly traded.
What exchange does ProKidney Corp. - Class A Ordinary Shares trade on?
ProKidney Corp. - Class A Ordinary Shares trades on the Nasdaq Stock Market
What is the ticker symbol for ProKidney Corp. - Class A Ordinary Shares?
The ticker symbol for ProKidney Corp. - Class A Ordinary Shares is PROK on the Nasdaq Stock Market
What is the current price of ProKidney Corp. - Class A Ordinary Shares?
The current price of ProKidney Corp. - Class A Ordinary Shares is 2.480
When was ProKidney Corp. - Class A Ordinary Shares last traded?
The last trade of ProKidney Corp. - Class A Ordinary Shares was at 09/12/25 04:00 PM ET
What is the market capitalization of ProKidney Corp. - Class A Ordinary Shares?
The market capitalization of ProKidney Corp. - Class A Ordinary Shares is 152.62M
How many shares of ProKidney Corp. - Class A Ordinary Shares are outstanding?
ProKidney Corp. - Class A Ordinary Shares has 153M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.